Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways
The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for t...
Gespeichert in:
Veröffentlicht in: | Journal of comparative neurology (1911) 1995-05, Vol.355 (4), p.615-628 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 628 |
---|---|
container_issue | 4 |
container_start_page | 615 |
container_title | Journal of comparative neurology (1911) |
container_volume | 355 |
creator | Miller, Brad Sheppard, Allan M. Bicknese, Alma R. Pearlman, Alan L. |
description | The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents. |
doi_str_mv | 10.1002/cne.903550410 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77438457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77438457</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS0EKmlhyRLJK3ZT7HrGP-wgLQEpKpsiJDaWx3PdGCZ2sD00eRjetQ6JIlZsbFnnnE_X9yD0ipJLSsjVWxvgUhHWdaSl5AmaUaJ4oySnT9Gs6rRRiovn6DznH4QQpZg8Q2eCM14zM_RnvophSNEXH3CeRmcK4E2KBeL9uLMmZFyFsgI8wG8Y48aHe2whQZ_MiG1MBbbv8N1e97kk30_Fx4CjwwGmFCvgr1BTk88ryNjFtN4zjHOVEgo2YcBwemxjqNyNKasHs8sv0DNnxgwvj_cF-vrx5m7-qVl-WXyev182tm0JaZxprWHyygEF13VSSck7xgU4Vk_Rqn6QwwCDkKzlzMneCsUddYQL6bhU7AK9OXDrz39NkIte-2xhHE2AOGVdGUy2najG5mC0KeacwOlN8muTdpoSva9D1zr0qY7qf30ET_0ahpP7uP-qi4P-4EfY_R-m57c3_5KPk9TtwvaUNOmn5oKJTn-7XejFtWIf5LLT39kj6jSpkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77438457</pqid></control><display><type>article</type><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</creator><creatorcontrib>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</creatorcontrib><description>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</description><identifier>ISSN: 0021-9967</identifier><identifier>EISSN: 1096-9861</identifier><identifier>DOI: 10.1002/cne.903550410</identifier><identifier>PMID: 7636035</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Afferent Pathways - cytology ; Afferent Pathways - embryology ; Afferent Pathways - metabolism ; Animals ; Antibodies, Monoclonal ; Axons - metabolism ; Cerebral Cortex - cytology ; Cerebral Cortex - embryology ; Cerebral Cortex - metabolism ; Chondroitin Lyases ; Chondroitin Sulfate Proteoglycans - metabolism ; Chondroitin Sulfates - metabolism ; development ; Efferent Pathways - cytology ; Efferent Pathways - embryology ; Efferent Pathways - metabolism ; extracellular matrix ; Female ; glycosaminoglycan ; Glycosaminoglycans - metabolism ; Immunohistochemistry ; Lectins, C-Type ; Nerve Tissue Proteins - metabolism ; Pregnancy ; Rats ; Thalamus - cytology ; Thalamus - embryology ; Thalamus - metabolism ; Vibrissae - innervation</subject><ispartof>Journal of comparative neurology (1911), 1995-05, Vol.355 (4), p.615-628</ispartof><rights>Copyright © 1995 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</citedby><cites>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcne.903550410$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcne.903550410$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7636035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Brad</creatorcontrib><creatorcontrib>Sheppard, Allan M.</creatorcontrib><creatorcontrib>Bicknese, Alma R.</creatorcontrib><creatorcontrib>Pearlman, Alan L.</creatorcontrib><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><title>Journal of comparative neurology (1911)</title><addtitle>J. Comp. Neurol</addtitle><description>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</description><subject>Afferent Pathways - cytology</subject><subject>Afferent Pathways - embryology</subject><subject>Afferent Pathways - metabolism</subject><subject>Animals</subject><subject>Antibodies, Monoclonal</subject><subject>Axons - metabolism</subject><subject>Cerebral Cortex - cytology</subject><subject>Cerebral Cortex - embryology</subject><subject>Cerebral Cortex - metabolism</subject><subject>Chondroitin Lyases</subject><subject>Chondroitin Sulfate Proteoglycans - metabolism</subject><subject>Chondroitin Sulfates - metabolism</subject><subject>development</subject><subject>Efferent Pathways - cytology</subject><subject>Efferent Pathways - embryology</subject><subject>Efferent Pathways - metabolism</subject><subject>extracellular matrix</subject><subject>Female</subject><subject>glycosaminoglycan</subject><subject>Glycosaminoglycans - metabolism</subject><subject>Immunohistochemistry</subject><subject>Lectins, C-Type</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Thalamus - cytology</subject><subject>Thalamus - embryology</subject><subject>Thalamus - metabolism</subject><subject>Vibrissae - innervation</subject><issn>0021-9967</issn><issn>1096-9861</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1uEzEUhS0EKmlhyRLJK3ZT7HrGP-wgLQEpKpsiJDaWx3PdGCZ2sD00eRjetQ6JIlZsbFnnnE_X9yD0ipJLSsjVWxvgUhHWdaSl5AmaUaJ4oySnT9Gs6rRRiovn6DznH4QQpZg8Q2eCM14zM_RnvophSNEXH3CeRmcK4E2KBeL9uLMmZFyFsgI8wG8Y48aHe2whQZ_MiG1MBbbv8N1e97kk30_Fx4CjwwGmFCvgr1BTk88ryNjFtN4zjHOVEgo2YcBwemxjqNyNKasHs8sv0DNnxgwvj_cF-vrx5m7-qVl-WXyev182tm0JaZxprWHyygEF13VSSck7xgU4Vk_Rqn6QwwCDkKzlzMneCsUddYQL6bhU7AK9OXDrz39NkIte-2xhHE2AOGVdGUy2najG5mC0KeacwOlN8muTdpoSva9D1zr0qY7qf30ET_0ahpP7uP-qi4P-4EfY_R-m57c3_5KPk9TtwvaUNOmn5oKJTn-7XejFtWIf5LLT39kj6jSpkw</recordid><startdate>19950515</startdate><enddate>19950515</enddate><creator>Miller, Brad</creator><creator>Sheppard, Allan M.</creator><creator>Bicknese, Alma R.</creator><creator>Pearlman, Alan L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950515</creationdate><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><author>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Afferent Pathways - cytology</topic><topic>Afferent Pathways - embryology</topic><topic>Afferent Pathways - metabolism</topic><topic>Animals</topic><topic>Antibodies, Monoclonal</topic><topic>Axons - metabolism</topic><topic>Cerebral Cortex - cytology</topic><topic>Cerebral Cortex - embryology</topic><topic>Cerebral Cortex - metabolism</topic><topic>Chondroitin Lyases</topic><topic>Chondroitin Sulfate Proteoglycans - metabolism</topic><topic>Chondroitin Sulfates - metabolism</topic><topic>development</topic><topic>Efferent Pathways - cytology</topic><topic>Efferent Pathways - embryology</topic><topic>Efferent Pathways - metabolism</topic><topic>extracellular matrix</topic><topic>Female</topic><topic>glycosaminoglycan</topic><topic>Glycosaminoglycans - metabolism</topic><topic>Immunohistochemistry</topic><topic>Lectins, C-Type</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Thalamus - cytology</topic><topic>Thalamus - embryology</topic><topic>Thalamus - metabolism</topic><topic>Vibrissae - innervation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Brad</creatorcontrib><creatorcontrib>Sheppard, Allan M.</creatorcontrib><creatorcontrib>Bicknese, Alma R.</creatorcontrib><creatorcontrib>Pearlman, Alan L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of comparative neurology (1911)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Brad</au><au>Sheppard, Allan M.</au><au>Bicknese, Alma R.</au><au>Pearlman, Alan L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</atitle><jtitle>Journal of comparative neurology (1911)</jtitle><addtitle>J. Comp. Neurol</addtitle><date>1995-05-15</date><risdate>1995</risdate><volume>355</volume><issue>4</issue><spage>615</spage><epage>628</epage><pages>615-628</pages><issn>0021-9967</issn><eissn>1096-9861</eissn><abstract>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7636035</pmid><doi>10.1002/cne.903550410</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9967 |
ispartof | Journal of comparative neurology (1911), 1995-05, Vol.355 (4), p.615-628 |
issn | 0021-9967 1096-9861 |
language | eng |
recordid | cdi_proquest_miscellaneous_77438457 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
subjects | Afferent Pathways - cytology Afferent Pathways - embryology Afferent Pathways - metabolism Animals Antibodies, Monoclonal Axons - metabolism Cerebral Cortex - cytology Cerebral Cortex - embryology Cerebral Cortex - metabolism Chondroitin Lyases Chondroitin Sulfate Proteoglycans - metabolism Chondroitin Sulfates - metabolism development Efferent Pathways - cytology Efferent Pathways - embryology Efferent Pathways - metabolism extracellular matrix Female glycosaminoglycan Glycosaminoglycans - metabolism Immunohistochemistry Lectins, C-Type Nerve Tissue Proteins - metabolism Pregnancy Rats Thalamus - cytology Thalamus - embryology Thalamus - metabolism Vibrissae - innervation |
title | Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A36%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chondroitin%20sulfate%20proteoglycans%20in%20the%20developing%20cerebral%20cortex:%20The%20distribution%20of%20neurocan%20distinguishes%20forming%20afferent%20and%20efferent%20axonal%20pathways&rft.jtitle=Journal%20of%20comparative%20neurology%20(1911)&rft.au=Miller,%20Brad&rft.date=1995-05-15&rft.volume=355&rft.issue=4&rft.spage=615&rft.epage=628&rft.pages=615-628&rft.issn=0021-9967&rft.eissn=1096-9861&rft_id=info:doi/10.1002/cne.903550410&rft_dat=%3Cproquest_cross%3E77438457%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77438457&rft_id=info:pmid/7636035&rfr_iscdi=true |